WC
APEN

Wexford Capital’s Apollo Endosurgery, Inc. APEN Stock Holding History

Wexford Capital’s Portfolio APEN Stock Details APEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-205,000
Closed -$1.43M – 179
2018
Q2 		$1.43M Buy
+205,000
New +$1.27M 0.09% 77

Other funds holding APEN

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

Wexford Capital's APEN Position: Q3 2018 in Review

Wexford Capital sold out of Apollo Endosurgery, Inc. (APEN) in Q3 2018, closing a stake of 205,000 shares — an estimated $1.43M sold.

Wexford Capital first reported a position in APEN in Q2 2018 and held it in 1 quarter. The position peaked at $1.43M in Q2 2018. 38 funds tracked by Wall St. Rank hold APEN as of Q3 2018.

  • Wexford Capital reported no remaining Apollo Endosurgery, Inc. position as of Q3 2018 after selling out during the quarter.
  • Wexford Capital sold 205,000 Apollo Endosurgery, Inc. shares in Q3 2018, an estimated $1.43M.
  • Wexford Capital first reported a position in Apollo Endosurgery, Inc. in Q2 2018 and held it in 1 quarter.
  • Wexford Capital's Apollo Endosurgery, Inc. position peaked at $1.43M in Q2 2018.
  • 38 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q3 2018.

Based on Wexford Capital's 13F filing for Q3 2018, filed 14 Nov 2018.